drugset / Trial / NCT01852539
Dexmedetomidine for Laryngeal Mask Airway Insertion
NaSingle-groupDouble-blindTreatment
Summary
The investigators attempted to determine the optimal dose of dexmedetomidine required for the successful insertion of LMA during propofol induction without a neuromuscular blocking agent.
Timeline
- Start
- 2013-07
- Primary completion
- 2013-08
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.5 ug/kg | Intravenous |
| Background | Propofol | Small molecule | 2 mg/kg | — |
Indications
No indication recorded.